Table 3.
Multivariate analysis of DFS in the training cohort.
Variable | Hazard ratio (95% CI) | P-value |
---|---|---|
Rad-score | 3.95 (1.87–8.37) | 0.0003 |
Lymphovascular invasion Absent Present |
reference 2.19 (1.14–4.21) |
/0.018 |
Molecular subtype Luminal A Luminal B HER2-enriched Triple-negative |
reference 2.04 (0.61–6.81) 3.12 (0.80–12.18) 3.15 (0.75–12.43) |
/0.247 0.031 0.038 |
N stage 0 1 2 3 |
reference 2.86 (1.21–6.73) 3.81 (1.46–9.97) 3.93 (1.15–12.31) |
/0.016 0.006 0.007 |
T stage 1 2 3 4 |
Reference 1.46 (0.68–3.11) 2.90 (0.89–9.43) 0.80 (0.10–6.79) |
/0.332 0.076 0.842 |
Rad-score, radiomics score; CI, confidence interval.